Screener
Emergent Biosolutions EBS Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Emergent Biosolutions’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 5, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001367644-26-000082
FAQ
- What is Emergent Biosolutions's total equity?
- Emergent Biosolutions (EBS) reported total equity of $341.4M in Q2 2026.
- How has Emergent Biosolutions's total equity changed year-over-year?
- Emergent Biosolutions's total equity decreased by 36.3% year-over-year, from $536.2M to $341.4M.
- What is the long-term trend for Emergent Biosolutions's total equity?
- Over 5 years (2020 to 2025), Emergent Biosolutions's total equity has grown at a -18.5% compound annual growth rate (CAGR), from $1.45B to $522.6M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Emergent Biosolutions's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude